Your browser doesn't support javascript.
loading
Testosterone Pathway Genetic Polymorphisms in Relation to Primary Open-Angle Glaucoma: An Analysis in Two Large Datasets.
Bailey, Jessica N Cooke; Gharahkhani, Puya; Kang, Jae H; Butkiewicz, Mariusz; Sullivan, David A; Weinreb, Robert N; Aschard, Hugues; Allingham, R Rand; Ashley-Koch, Allison; Lee, Richard K; Moroi, Sayoko E; Brilliant, Murray H; Wollstein, Gadi; Schuman, Joel S; Fingert, John H; Budenz, Donald L; Realini, Tony; Gaasterland, Terry; Scott, William K; Singh, Kuldev; Sit, Arthur J; Igo, Robert P; Song, Yeunjoo E; Hark, Lisa; Ritch, Robert; Rhee, Douglas J; Vollrath, Douglas; Zack, Donald J; Medeiros, Felipe; Vajaranant, Thasarat S; Chasman, Daniel I; Christen, William G; Pericak-Vance, Margaret A; Liu, Yutao; Kraft, Peter; Richards, Julia E; Rosner, Bernard A; Hauser, Michael A; Craig, Jamie E; Burdon, Kathryn P; Hewitt, Alex W; Mackey, David A; Haines, Jonathan L; MacGregor, Stuart; Wiggs, Janey L; Pasquale, Louis R.
Afiliación
  • Bailey JNC; Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States.
  • Gharahkhani P; Institute for Computational Biology, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States.
  • Kang JH; Statistical Genetics, QIMR Berghofer Medical Research Institute, Royal Brisbane Hospital, Brisbane, Australia.
  • Butkiewicz M; Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.
  • Sullivan DA; Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States.
  • Weinreb RN; Institute for Computational Biology, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States.
  • Aschard H; Schepens Eye Research Institute, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, United States.
  • Allingham RR; Department of Ophthalmology, Hamilton Glaucoma Center and Shiley Eye Institute, University of California at San Diego, La Jolla, California, United States.
  • Ashley-Koch A; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Harvard Medical School, Boston, Massachusetts, United States.
  • Lee RK; Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina, United States.
  • Moroi SE; Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States.
  • Brilliant MH; Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, United States.
  • Wollstein G; Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan, United States.
  • Schuman JS; Center for Human Genetics, Marshfield Clinic Research Institute, Marshfield, Wisconsin, United States.
  • Fingert JH; Department of Ophthalmology, NYU Langone Medical Center, NYU School of Medicine, New York, New York, United States.
  • Budenz DL; Department of Ophthalmology, NYU Langone Medical Center, NYU School of Medicine, New York, New York, United States.
  • Realini T; Departments of Ophthalmology and Anatomy/Cell Biology, University of Iowa, College of Medicine, Iowa City, Iowa, United States.
  • Gaasterland T; Department of Ophthalmology, University of North Carolina, Chapel Hill, North Carolina, United States.
  • Scott WK; Department of Ophthalmology, WVU Eye Institute, Morgantown, West Virginia, United States.
  • Singh K; Scripps Genome Center, University of California at San Diego, San Diego, California, United States.
  • Sit AJ; Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, Florida, United States.
  • Igo RP; Department of Ophthalmology, Stanford University, Palo Alto, California, United States.
  • Song YE; Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota, United States.
  • Hark L; Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States.
  • Ritch R; Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States.
  • Rhee DJ; Institute for Computational Biology, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States.
  • Vollrath D; Wills Eye Hospital, Glaucoma Research Center, Philadelphia, Pennsylvania, United States.
  • Zack DJ; Einhorn Clinical Research Center, New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States.
  • Medeiros F; Department of Ophthalmology, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States.
  • Vajaranant TS; Department of Genetics, Stanford University, Palo Alto, California, United States.
  • Chasman DI; Wilmer Eye Institute, Johns Hopkins University Hospital, Baltimore, Maryland, United States.
  • Christen WG; Department of Ophthalmology, Hamilton Glaucoma Center and Shiley Eye Institute, University of California at San Diego, La Jolla, California, United States.
  • Pericak-Vance MA; Department of Ophthalmology, University of Illinois College of Medicine at Chicago, Chicago, Illinois, United States.
  • Liu Y; Division of Preventive Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States.
  • Kraft P; Division of Preventive Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States.
  • Richards JE; Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, Florida, United States.
  • Rosner BA; Department of Cellular Biology and Anatomy, Augusta University, Augusta, Georgia, United States.
  • Hauser MA; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Harvard Medical School, Boston, Massachusetts, United States.
  • Craig JE; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Harvard Medical School, Boston, Massachusetts, United States.
  • Burdon KP; Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan, United States.
  • Hewitt AW; Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.
  • Mackey DA; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Harvard Medical School, Boston, Massachusetts, United States.
  • Haines JL; Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina, United States.
  • MacGregor S; Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States.
  • Wiggs JL; Department of Ophthalmology, Flinders University, Adelaide, SA, Australia.
  • Pasquale LR; School of Medicine, Menzies Research Institute of Tasmania, Hobart, Australia.
Invest Ophthalmol Vis Sci ; 59(2): 629-636, 2018 02 01.
Article en En | MEDLINE | ID: mdl-29392307
ABSTRACT

Purpose:

Sex hormones may be associated with primary open-angle glaucoma (POAG), although the mechanisms are unclear. We previously observed that gene variants involved with estrogen metabolism were collectively associated with POAG in women but not men; here we assessed gene variants related to testosterone metabolism collectively and POAG risk.

Methods:

We used two datasets one from the United States (3853 cases and 33,480 controls) and another from Australia (1155 cases and 1992 controls). Both datasets contained densely called genotypes imputed to the 1000 Genomes reference panel. We used pathway- and gene-based approaches with Pathway Analysis by Randomization Incorporating Structure (PARIS) software to assess the overall association between a panel of single nucleotide polymorphisms (SNPs) in testosterone metabolism genes and POAG. In sex-stratified analyses, we evaluated POAG overall and POAG subtypes defined by maximum IOP (high-tension [HTG] or normal tension glaucoma [NTG]).

Results:

In the US dataset, the SNP panel was not associated with POAG (permuted P = 0.77), although there was an association in the Australian sample (permuted P = 0.018). In both datasets, the SNP panel was associated with POAG in men (permuted P ≤ 0.033) and not women (permuted P ≥ 0.42), but in gene-based analyses, there was no consistency on the main genes responsible for these findings. In both datasets, the testosterone pathway association with HTG was significant (permuted P ≤ 0.011), but again, gene-based analyses showed no consistent driver gene associations.

Conclusions:

Collectively, testosterone metabolism pathway SNPs were consistently associated with the high-tension subtype of POAG in two datasets.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Testosterona / Glaucoma de Ángulo Abierto / Polimorfismo de Nucleótido Simple / Redes y Vías Metabólicas Tipo de estudio: Clinical_trials Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Invest Ophthalmol Vis Sci Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Testosterona / Glaucoma de Ángulo Abierto / Polimorfismo de Nucleótido Simple / Redes y Vías Metabólicas Tipo de estudio: Clinical_trials Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Invest Ophthalmol Vis Sci Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos